Naviscan PET scanners performing positron emission mammography (PEM) have been installed in two European centers: Radiologie und Nuklearmedizin in Ludwigshafen, Germany, and Medica in Istanbul, Turkey.
University of Texas (UT) Southwestern Medical Center in Dallas has installed a PET scanner, the breast application for which is positron emission mammography (PEM), which will be used both for clinical patients as well as for research focused on lowering radiation dose and novel radiotracers.
Naviscan has obtained CE mark approval for its high-resolution PET scanner and PET-guided biopsy accessory. The breast application of the scanner is Positron Emission Mammography (PEM).
The American Journal of Roentgenology has published two separate studies this month demonstrating the clinical acceptance of Naviscan’s Positron Emission Mammography (PEM) scanner. The first study concluded that breast radiologists can achieve a high level of diagnostic performance in interpreting PEM images after a two-hour tutorial. The second study established a standard lexicon for the evaluation of PEM images.
Prospective data confirming the technical validity of image-guided needle biopsy of suspicious breast cancer lesions using Positron Emission Mammography (PEM) guidance has been published in the March/April issue of the Breast Journal.
Naviscan has entered into an exclusive licensing agreement with Neoprobe as a partner to develop its patented imaging technology.
RSS 
